Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Knutson

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Therapeutic vaccines for malignant brain tumorsMichael P Gustafson, Keith L Knutson, Allan B Dietz
Journal of Visualized Experiments : Jove|August 17, 2012
Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence systemCourtney L Erskine, Andrea M Henle, Keith L Knutson
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Laboratory analysis of T-cell immunityKeith L Knutson, Corazon dela Rosa, Mary Lenora Disis
Cancer Immunology, Immunotherapy : CII|July 5, 2006
CD4 regulatory T cells in human cancer pathogenesisKeith L Knutson, Mary L Disis, Lupe G Salazar
Cancer Research|April 17, 2010
Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cellsJennifer M Reiman, Keith L Knutson, Derek C Radisky
Cancer Metastasis Reviews|December 30, 2014
Targeted immune therapy of ovarian cancerKeith L Knutson, Lavakumar Karyampudi, Purushottam Lamichhane, et al.
Cancer Research|February 12, 2004
Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic miceKeith L Knutson, Bond Almand, Yushe Dang, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Immunotherapy of glioblastoma multiformeKeith L Knutson, Lupe Salazar, Kathy Schiffman, et al.
Journal of Clinical Immunology|September 11, 2004
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patientsMary L Disis, Vivian Goodell, Kathy Schiffman, et al.
Cancer Research|October 5, 2006
The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigensHailing Lu, Keith L Knutson, Ekram Gad, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Biologics : Targets & Therapy|August 27, 2009
Therapeutic vaccines for malignant brain tumorsMichael P Gustafson, Keith L Knutson, Allan B Dietz
Journal of Visualized Experiments : Jove|August 17, 2012
Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence systemCourtney L Erskine, Andrea M Henle, Keith L Knutson
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Laboratory analysis of T-cell immunityKeith L Knutson, Corazon dela Rosa, Mary Lenora Disis
Cancer Immunology, Immunotherapy : CII|July 5, 2006
CD4 regulatory T cells in human cancer pathogenesisKeith L Knutson, Mary L Disis, Lupe G Salazar
Cancer Research|April 17, 2010
Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cellsJennifer M Reiman, Keith L Knutson, Derek C Radisky
Cancer Metastasis Reviews|December 30, 2014
Targeted immune therapy of ovarian cancerKeith L Knutson, Lavakumar Karyampudi, Purushottam Lamichhane, et al.
Cancer Research|February 12, 2004
Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic miceKeith L Knutson, Bond Almand, Yushe Dang, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Immunotherapy of glioblastoma multiformeKeith L Knutson, Lupe Salazar, Kathy Schiffman, et al.
Journal of Clinical Immunology|September 11, 2004
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patientsMary L Disis, Vivian Goodell, Kathy Schiffman, et al.
Cancer Research|October 5, 2006
The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigensHailing Lu, Keith L Knutson, Ekram Gad, et al.
Pageof 15